Product Pipeline

Genflow Biosciences' leading compound is GF-1002, mRNA-LNP (Lipid Nano Particles) expressing SIRT6c. This innovative therapy delivers a variant of the human SIRT6 gene, which is associated with longevity in centenarians. Additionally, our product pipeline includes a variety of cutting-edge gene delivery solutions aimed at providing therapeutic benefits across several clinical conditions with significant unmet medical needs.

Genflow Science Pipeline Chart original 2026 08 v1

Newsletter

To stay up to date with news, events and more, sign up to our mailing list and follow our social media

Subscription Form

Contact

For more information on Genflow Bioscience and our science, get in touch.

Get in touch

Company

About
Leadership
Careers

Science

Overview
Product Pipeline
Clinical Programs

News

RNS
Insights
Publications

Follow Genflow Bioscience on LinkedIn
Follow Genflow Bioscience on X (twitter)
Follow Genflow Bioscience on Instagram

Privacy Policy
Disclaimer
Terms of Use

Home
About
- Leadership
Genflow Biosciences
- Product Pipeline
- Clinical Programs
Investors
Contact
Publications